Only B lymphocytes induce active enhancement of rat cardiac allografts

Transplantation
W LauchartD A Davies

Abstract

LEW rats were immunized 7 days before (LEW X BN)F1 heart transplantation with 10(7) BN donor cells, either purified erythrocytes (RBC), peripheral blood (PBL), splenic, nylon-wool-adherent (B-enriched) or nylon-wool-nonadherent (T-enriched) lymphocytes. Allograft rejection was only significantly enhanced in animals pretreated with lymphocyte populations containing surface immunoglobulin (SIgG)-positive cells (PBL, splenic, or B-enriched lymphocytes). Recipients immunized with RBC or T-enriched lymphocytes containing few, if any, SIgG-bearing B lymphocytes showed no significant graft prolongation.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.